Elite in Nonalcoholic Steatohepatitis (NASH)
Check Dr. Mohammad B. Siddiqui's experience treating your condition:
About Dr. Mohammad B. Siddiqui

Mohammad Siddiqui is a Gastroenterologist in Richmond, Virginia. Siddiqui has been practicing medicine for over 2 years and is rated as an Elite expert by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). He is also highly rated in 9 other conditions, according to our data. His top areas of expertise are Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), Alcoholic Cirrhosis, Liver Transplant, and Endoscopy. He is licensed to treat patients in Virginia. Siddiqui is currently accepting new patients.

His clinical research consists of co-authoring 156 peer reviewed articles and participating in 7 clinical trials in the past 15 years. In particular, he has co-authored 62 articles and participated in 5 clinical trials in the study of Nonalcoholic Steatohepatitis (NASH).


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Mohammad B. Siddiqui it is best to call his office and ask if your insurance is accepted.

Accepts Medicare
7611 Forest Ave, Richmond, VA 23229
Background & Education
Graduate Institution
Virginia Commonwealth University, School Of Medicine, 2020
Hospital Affiliations
Henrico Doctors Hospital
St Francis Medical Center
VCU Medical Center Main Hospital
Johnston-Willis Hospital
St Marys Hospital
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Impact of a Low Carbohydrate Diet (LCD) on Metabolic Inflexibility and Cardiovascular Risk in Liver Transplant (LT) Patients
A Randomized Double Blinded Placebo-Controlled Trial of Semaglutide to Prevent Weight Gain Following Liver Transplantation
View 6 Less Clinical Trials -

145 Total Publications

Meta-analysis of the Placebo and Nocebo Effects Associated with Placebo Treatment in Randomized Trials of Lipid Lowering Therapy.

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors